Cha-Cha Ong
Analyst at Jefferies
Replay available
Corvus Pharmaceuticals, Inc. (CRVS) Q3 2025 Earnings Call
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Lee Wacek
Analyst at Kantor
Adrian Hasino
Analyst at Landenberg
Sean Lee
Analyst at H.C. Wainwright
Leif Lee
Chief Financial Officer of Corvus Pharmaceuticals
Jeff Jones
Analyst at Oppenheimer
Greg Cervazave
Analyst at Mizuho Securities
Richard Miller
Chief Executive Officer of Corvus Pharmaceuticals
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Corvus Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.258 Good afternoon, everyone. Thank you for standing by, and welcome to the Corvus Pharmaceuticals 00:00:04.258 -- 00:00:09.406 Third Quarter 2025 Business Update and Financial Results Conference Call. 00:00:09.406 -- 00:00:12.711 At this time, all participants are in listen-only mode. 00:00:12.711 -- 00:00:16.698 Later, we will conduct a question-and-answer session, and instructions will follow at 00:00:16.698 -- 00:00:21.886 that time. It is now a pleasure to turn the call over to Zach Kubo of Real Chemistry. 00:00:21.886 -- 00:00:24.487 Please go ahead, sir. 00:00:24.891 -- 00:00:27.740 Thank you, Operator, and good afternoon, everyone. 00:00:27.740 -- 00:00:32.367 Thanks for joining us for the Corvus Pharmaceuticals Third Quarter 2025 00:00:32.367 -- 00:00:36.113 Business Update and Financial Results Conference Call. 00:00:36.113 -- 00:00:40.760 On the call to discuss the results and business updates are Richard Miller, Chief Executive 00:00:40.760 -- 00:00:46.108 Officer, Leif Lee, Chief Financial Officer, Jeff Varkara, Chief Business 00:00:46.108 -- 00:00:52.037 Officer, and Ben Jones, Senior Vice President of Regulatory and Pharmaceutical Sciences. 00:00:52.037 -- 00:00:56.263 The executive team will open the call with some prepared remarks, followed by a question 00:00:56.263 -- 00:01:00.955 and answer period. I would like to remind everyone that comments made by management today 00:01:00.955 -- 00:01:04.860 and answers to questions will include forward-looking statements. 00:01:04.860 -- 00:01:09.425 Forward-looking statements are based on estimates and assumptions as of today and are 00:01:09.425 -- 00:01:14.190 subject to risks and uncertainties that may cause actual results to differ materially 00:01:14.190 -- 00:01:18.655 ...